Selected article for: "chronic disease and pneumococcal vaccine"
Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
  • Document date: 2018_2_27
    • ID: t9tysvr8_71
    Snippet: No potential conflict of interest relevant to this article was reported. HSCT, hematopoietic stem cell transplantation. a Following the three doses of 13-valent pneumococcal conjugate vaccine (PCV), a dose of 23-valent polysaccharide pneumococcal vaccine may be given to broaden the covered spectrum. In HSCT recipients with chronic graft-versus-host disease (GVHD) who are likely to respond poorly to polysaccharide vaccine, a fourth PCV should be c.....
    Document: No potential conflict of interest relevant to this article was reported. HSCT, hematopoietic stem cell transplantation. a Following the three doses of 13-valent pneumococcal conjugate vaccine (PCV), a dose of 23-valent polysaccharide pneumococcal vaccine may be given to broaden the covered spectrum. In HSCT recipients with chronic graft-versus-host disease (GVHD) who are likely to respond poorly to polysaccharide vaccine, a fourth PCV should be considered at intervals of more than 6 months.

    Search related documents:
    Co phrase search for related documents
    • chronic GVHD host versus graft disease and hematopoietic stem cell transplantation: 1, 2, 3, 4, 5, 6, 7, 8
    • chronic GVHD host versus graft disease and host versus graft: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • chronic GVHD host versus graft disease and host versus graft disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • chronic GVHD host versus graft disease and hsct recipient: 1
    • conjugate vaccine and PCV pneumococcal conjugate vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • conjugate vaccine and pneumococcal conjugate vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • conjugate vaccine and pneumococcal vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • conjugate vaccine and polysaccharide pneumococcal vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • conjugate vaccine and polysaccharide vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • GVHD host versus graft disease and hematopoietic stem cell transplantation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • GVHD host versus graft disease and host versus graft: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • GVHD host versus graft disease and host versus graft disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • GVHD host versus graft disease and hsct recipient: 1, 2
    • hematopoietic stem cell transplantation and host versus graft: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • hematopoietic stem cell transplantation and host versus graft disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • hematopoietic stem cell transplantation and hsct recipient: 1, 2, 3, 4, 5, 6
    • host versus graft and hsct recipient: 1, 2
    • host versus graft disease and hsct recipient: 1, 2
    • PCV pneumococcal conjugate vaccine and polysaccharide vaccine: 1, 2